Literature DB >> 4506787

Thiolester substrates for transamidating enzymes: studies on fibrinoligase.

L Lorand, C H Chou, I Simpson.   

Abstract

Esters of thiocholine were shown to inhibit the crosslinking of fibrin clots by the transamidating enzyme, fibrinoligase (thrombin-activated fibrin-stabilizing factor or activated Factor XIII). Inhibition depended on the nature of the acylating group with the phenylpropionyl, phenylbutyryl, and trans-cinnamoyl esters being most effective of the compounds tested so far. Use of the thiolesters made it possible for the first time to study the reactions of fibrinoligase in fully synthetic substrate systems. Enzyme-catalyzed acyl-group transfers from the thiol-esters to a fluorescent amine [N-(5-aminopentyl) - 5 - dimethylamino - 1 - naphthalenesulfonamide] could be readily demonstrated and measured.Trans-cinnamoylthiocholine reacted with fibrinoligase in a totally calcium-dependent manner in the absence of any added amine, thus providing the first evidence for an esterolytic pathway for this enzyme. Spectral qualities, as well as appreciable extent of solubility in water, would seem to make trans-cinnamoylthiocholine a specially suitable substrate for further studies.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4506787      PMCID: PMC427007          DOI: 10.1073/pnas.69.9.2645

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  6 in total

1.  Equilibria in the fibrinogen-fibrin conversion. II. Reversibility of the polymerization steps.

Authors:  T H DONNELLY; M LASKOWSKI; N NOTLEY; H A SCHERAGA
Journal:  Arch Biochem Biophys       Date:  1955-06       Impact factor: 4.013

2.  Transamidating enzymes. II. A continuous fluorescent method suited for automating measurements of factor XIII in plasma.

Authors:  L Lorand; O M Lockridge; L K Campbell; R Myhrman; J Bruner-Lorand
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

3.  Transamidating enzymes. I. Rapid chromatographic assays.

Authors:  L Lorand; L K Campbell
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

4.  Amine specificity in transpeptidation. Inhibition of fibrin cross-linking.

Authors:  L Lorand; N G Rule; H H Ong; R Furlanetto; A Jacobsen; J Downey; N Oner; J Bruner-Lorand
Journal:  Biochemistry       Date:  1968-03       Impact factor: 3.162

5.  The transpeptidase system which crosslinks fibrin by gamma-glutamyle-episilon-lysine bonds.

Authors:  L Lorand; J Downey; T Gotoh; A Jacobsen; S Tokura
Journal:  Biochem Biophys Res Commun       Date:  1968-04-19       Impact factor: 3.575

6.  Mechanism of action of guinea pig liver transglutaminase. I. Purification and properties of the enzyme: identification of a functional cysteine essential for activity.

Authors:  J E Folk; P W Cole
Journal:  J Biol Chem       Date:  1966-12-10       Impact factor: 5.157

  6 in total
  7 in total

1.  A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.

Authors:  L Lorand; K N Parameswaran; S N Murthy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 2.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

3.  Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines.

Authors:  P Stenberg; C G Curtis; D Wing; Y S Tong; R B Credo; A Gray; L Lorand
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

4.  Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity.

Authors:  S N Prasanna Murthy; Siiri Iismaa; Gillian Begg; Douglas M Freymann; Robert M Graham; Laszlo Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  Calcium and the assays of human plasma clotting factor XIII.

Authors:  R D Cooke; J J Holbrook
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

6.  Calcium and thiol reactivity of human plasma clotting factor XIII.

Authors:  R D Cooke; T C Pestell; J J Holbrook
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

7.  Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.

Authors:  Sneha Gupta; Arijit Biswas; Mohammad Suhail Akhter; Christoph Krettler; Christoph Reinhart; Johannes Dodt; Andreas Reuter; Helen Philippou; Vytautas Ivaskevicius; Johannes Oldenburg
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.